Jade Biosciences (JBIO) Net Income Growth (1y) (2021 - 2026)
Jade Biosciences (JBIO) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Jade Biosciences | 1.18 Bn | 866.20 Mn | - | -5.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.98% |
| Dec 31, 2025 | 25.54% |
| Sep 30, 2025 | -264.27% |
| Jun 30, 2025 | -160.47% |
| Mar 31, 2025 | 67.68% |
| Dec 31, 2024 | -111.76% |
| Sep 30, 2024 | 60.20% |
| Jun 30, 2024 | 46.52% |
| Mar 31, 2024 | -95.99% |
| Dec 31, 2023 | -40.57% |
| Sep 30, 2023 | 19.01% |
| Jun 30, 2023 | -14.61% |
| Mar 31, 2023 | -452.25% |
| Dec 31, 2022 | -90.90% |
| Sep 30, 2022 | 0.70% |
| Jun 30, 2022 | 17.60% |
| Mar 31, 2022 | -292.30% |
| Dec 31, 2021 | -130.21% |
| Sep 30, 2021 | -2,068.61% |
| Jun 30, 2021 | -3,174.65% |